Dyne Therapeutics (DYN) 10-Q2023 Q1 Quarterly report

Filed: 11 May 23, 7:26am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Good

New words: adapt, agent, aimed, appeal, attributable, backstopped, ballot, beneficiary, blocker, body, Britain, centralized, certainty, chill, CHMP, Circuit, clarified, Colorado, compounding, Connecticut, CTA, CTR, CUG, currency, debating, deducing, default, Denali, disposition, drew, effectuated, engendered, England, erasure, excise, FDIC, fulfill, Great, halted, Head, HMR, inflation, IRA, Ireland, judgement, justification, legitimize, light, loosely, MHRA, mifepristone, monthly, Northern, Note, outpace, outpatient, overhead, overrule, passage, pediatric, pivotal, propagation, proportion, protracted, receivership, regularly, Sanofi, Scotland, Secretary, serve, SI, Silicon, stay, stayed, steric, subsidy, Sunrise, threshold, true, turnover, tying, unitary, UPC, Utah, Valley, Virginia, voucher, warrant

Removed: accede, aforementioned, announcement, ARPA, assessed, back, biometric, border, branch, CAA, CEJU, coded, colloquially, commentary, commerce, Commissioner, compliant, contractually, COVID, deceptive, democratic, destination, destruction, divergence, divergent, dosing, doubt, EDPB, elimination, enact, enacting, endeavor, enhancement, expiry, explicit, fallen, FDPIC, FFCR, fined, fixed, formal, gathered, Globally, IBC, improperly, indirect, informed, Intelligence, intensive, interrupt, investigated, investor, IPO, lawful, loan, lodge, meantime, mechanism, misrepresentative, Morgan, NDA, organizational, percent, Piper, power, precise, procuring, progression, recommended, redirect, reformed, Rescue, residency, retroactively, reviewing, safeguarding, Sandler, shop, society, solution, spiked, spread, Stifel, supervisory, supplementary, sustained, Switzerland, taxation, temporarily, transferred, transposition, Treasurer, underway, underwriting, unfair, unvaried, upheld, vested, virtue, vulnerability, withdrew, worker, workplace

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

DYN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Richard Scalzo, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Report on Form 10-Q of Dyne Therapeutics, Inc. for the fiscal quarter ended March 31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Dyne Therapeutics, Inc.

/s/ Richard Scalzo

Richard Scalzo

Senior Vice President, Head of Finance and Administration

(Principal Financial and Accounting Officer)

May 11, 2023